MICRO-PARTICULATED NANOCAPSULES CONTAINING LOPINAVIR WITH ENHANCED ORAL BIOAVAILABILITY AND EFFICACY

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20160235749A1
SERIAL NO

15041610

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present disclosure provides controlled-release delivery systems for oral delivery of active agents, e.g. lopinavir, comprising micro-particulated with enhanced oral bioavailability and efficacy, which may be used for treating HIV.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTDHI TECH PARK EDMOND J SAFRA CAMPUS GIVAT RAM P O BOX 39135 JERUSALEM 91390

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
BENITA, Simon Tel Aviv, IL 31 540
NASSAR, Taher Kfar Tur'an, IL 21 119

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation